Drug Shortage Report for CIMETIDINE
Report ID | 14163 |
Drug Identification Number | 00487872 |
Brand name | APO CIMETIDINE TAB 300MG |
Common or Proper name | CIMETIDINE |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | CIMETIDINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-08-15 |
Actual start date | 2017-07-17 |
Estimated end date | 2017-08-31 |
Actual end date | 2017-08-18 |
Shortage status | Resolved |
Updated date | 2017-08-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2017-08-21 | French | Compare |
v7 | 2017-08-21 | English | Compare |
v6 | 2017-07-18 | English | Compare |
v5 | 2017-07-17 | French | Compare |
v4 | 2017-07-17 | English | Compare |
v3 | 2017-06-28 | French | Compare |
v2 | 2017-06-28 | English | Compare |
v1 | 2017-06-28 | English | Compare |
Showing 1 to 8 of 8